Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

No reported Operating Margin figures are available to summarize.

Operating Margin history

Percent of revenue · from the income statement

No Operating Margin data reported for this period type.

Operating Margin vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors Peer median
Operating Margin for ODTX and competitors
Company Period LTM level YoY 3-year change
PTGXProtagonist Therapeutics, Inc.LTM Jun 202620.7% +9.2 pp+150.6 pp
ANABAnaptysBio, Inc.LTM Mar 202617.6% +107.2 pp+1139.8 pp
SYRESpyre Therapeutics, Inc.LTM Sep 2026-276.5% ——
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-961.9% -168.3 pp-673.9 pp
ALMSAlumis Inc. Common StockLTM Jun 2026-6204.4% -4015.0 pp—
ODTXOdyssey Therapeutics, Inc.—— ——
ORKAOruka Therapeutics, Inc.FY2025— ——
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024— ——
IMUXImmunic, Inc.FY2025— ——
Peer median (excluding ODTX) -276.5%-79.5 pp+150.6 pp

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.